Related Experiment Video

Updated: Oct 14, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.3K

Obesity and Children

Nancy T Browne1

  • 125 Andrews Avenue, Falmouth, ME 04105, USA.

The Nursing Clinics of North America
|November 9, 2021
PubMed

Insights

Pediatric obesity negatively impacts children

Area of Science:

  • Pediatric healthcare
  • Obesity medicine

Background:

  • Pediatric obesity is a complex, chronic condition with significant metabolic and psychosocial consequences.
  • Weight-based victimization and microaggressions detrimentally affect children's mental and physical well-being.
  • Current evidence-based guidelines recommend individualized, stepwise treatment approaches for childhood obesity.

Purpose of the Study:

  • To highlight the crucial role of pediatric nurses in supporting children and adolescents with obesity.
  • To outline strategies for nurses to provide effective clinical management and psychosocial support.
  • To emphasize how nurses can combat obesity myths, bias, and discrimination.

Main Methods:

  • This article synthesizes current knowledge on pediatric obesity and the nursing role.
  • It reviews evidence-based guidelines for obesity treatment.
  • It discusses practical applications for nurses across various practice settings.

Main Results:

  • Pediatric nurses are uniquely positioned to provide affirmation and psychosocial support.
  • Nurses can deliver evidence-based obesity education and correct misinformation.
  • Modeling person-first language and actions by nurses can reduce stigma.

Conclusions:

  • Pediatric nurses play a vital role in improving the health outcomes of children with obesity.
  • Affirmation, clinical management, and psychosocial support are key nursing interventions.
  • Nurses can significantly impact children's lives by addressing bias and promoting understanding.

Keywords:
BullyingObesityObesity treatmentPediatricPharmacotherapySocial determinantsVictimizationWeight stigma

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

470
Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

4.7K

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
705
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
16
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
19
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
249
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21